Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation

Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare... AbbreviationsGBSGroup B streptococcusKey MessageBoth pregnant women and healthcare professionals were open to the idea of an antenatal Group B streptococcus vaccine and involvement in clinical trials of such a vaccine. Education and support from midwives would be key to successful implementation.IntroductionImmunization of pregnant women to protect both themselves and their infants is increasingly part of routine care both in the UK and worldwide. Current UK recommendations state that all pregnant women should receive a pertussis‐containing vaccine at 16–32 weeks’ gestation and the influenza vaccine during the influenza season, at any stage of gestation . There is evidence that these antenatal vaccines are both safe and effective at preventing disease both in the mother and the infant .Around 60–75% of UK pregnant women received the pertussis vaccine in 2016 , with a marked increase between winter 2015 and 2016 . However, uptake rates for influenza remain suboptimal with recent figures showing that only 43% of eligible pregnant women received the influenza vaccine in 2016 ; thus a significant proportion of pregnant women and their babies remain susceptible to potentially fatal, yet preventable, diseases.Antenatal immunization also offers the potential to target additional major neonatal pathogens including Group B streptococcus (GBS), the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Obstetricia Et Gynecologica Scandinavica Wiley

Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation

Download PDF
11 pages

Loading next page...
 
/lp/wiley/antenatal-vaccination-against-group-b-streptococcus-attitudes-of-vi1P81LPOE

References (32)

Publisher
Wiley
Copyright
Copyright © 2018 Acta Obstetricia et Gynecologica Scandinavica
ISSN
0001-6349
eISSN
1600-0412
DOI
10.1111/aogs.13288
pmid
29292509
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsGBSGroup B streptococcusKey MessageBoth pregnant women and healthcare professionals were open to the idea of an antenatal Group B streptococcus vaccine and involvement in clinical trials of such a vaccine. Education and support from midwives would be key to successful implementation.IntroductionImmunization of pregnant women to protect both themselves and their infants is increasingly part of routine care both in the UK and worldwide. Current UK recommendations state that all pregnant women should receive a pertussis‐containing vaccine at 16–32 weeks’ gestation and the influenza vaccine during the influenza season, at any stage of gestation . There is evidence that these antenatal vaccines are both safe and effective at preventing disease both in the mother and the infant .Around 60–75% of UK pregnant women received the pertussis vaccine in 2016 , with a marked increase between winter 2015 and 2016 . However, uptake rates for influenza remain suboptimal with recent figures showing that only 43% of eligible pregnant women received the influenza vaccine in 2016 ; thus a significant proportion of pregnant women and their babies remain susceptible to potentially fatal, yet preventable, diseases.Antenatal immunization also offers the potential to target additional major neonatal pathogens including Group B streptococcus (GBS), the

Journal

Acta Obstetricia Et Gynecologica Scandinavica – Wiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ; ;

There are no references for this article.